MERCK Kommanditgesellschaft auf Aktien

PINK:MKGAF USA Drug Manufacturers - Specialty & Generic
Market Cap
$16.21 Billion
Market Cap Rank
#1166 Global
#897 in USA
Share Price
$125.45
Change (1 day)
-11.54%
52-Week Range
$125.45 - $144.43
All Time High
$252.52
About

Merck KGaA operates as a science and technology company in Germany and internationally. It operates through Life Science, Healthcare, and Electronics segments. The Life Science segment offers tools, chemicals, and equipment for academic labs, biotech, and pharmaceutical manufacturers, as well as the industrial sector. This segment offers science and lab solutions comprising reagents, consumables,… Read more

MERCK Kommanditgesellschaft auf Aktien (MKGAF) - Cash Flow Conversion Efficiency

Latest cash flow conversion efficiency as of September 2025: 0.052x

Based on the latest financial reports, MERCK Kommanditgesellschaft auf Aktien (MKGAF) has a cash flow conversion efficiency ratio of 0.052x as of September 2025.

Cash flow conversion efficiency measures how effectively a company's net assets (equity) generate operating cash flow. It is calculated by dividing operating cash flow ($1.78 Billion) by net assets ($34.03 Billion). A higher ratio indicates that the company is more efficient at using its equity to generate cash flow from its core operations.

MERCK Kommanditgesellschaft auf Aktien - Cash Flow Conversion Efficiency Trend (2002–2024)

This chart illustrates how MERCK Kommanditgesellschaft auf Aktien's cash flow conversion efficiency has evolved over time, based on yearly financial data. Explore and compare other companies by cash flow conversion efficiency.

MERCK Kommanditgesellschaft auf Aktien Competitors by Cash Flow Conversion Efficiency

The table below lists competitors of MERCK Kommanditgesellschaft auf Aktien ranked by their cash flow conversion efficiency.

Annual Cash Flow Conversion Efficiency for MERCK Kommanditgesellschaft auf Aktien (2002–2024)

The table below shows the annual cash flow conversion efficiency of MERCK Kommanditgesellschaft auf Aktien from 2002 to 2024.

Year Net Assets Operating Cash Flow Cash Flow Conversion Efficiency Change
2024-12-31 $29.99 Billion $4.59 Billion 0.153x +8.13%
2023-12-31 $26.75 Billion $3.78 Billion 0.141x -13.64%
2022-12-31 $26.00 Billion $4.26 Billion 0.164x -24.02%
2021-12-31 $21.42 Billion $4.62 Billion 0.216x +5.49%
2020-12-31 $17.02 Billion $3.48 Billion 0.204x +28.15%
2019-12-31 $17.91 Billion $2.86 Billion 0.159x +23.82%
2018-12-31 $17.23 Billion $2.22 Billion 0.129x -32.82%
2017-12-31 $14.07 Billion $2.70 Billion 0.192x +6.95%
2016-12-31 $14.05 Billion $2.52 Billion 0.179x +4.95%
2015-12-31 $12.86 Billion $2.20 Billion 0.171x -25.52%
2014-12-31 $11.80 Billion $2.71 Billion 0.229x +14.03%
2013-12-31 $11.07 Billion $2.23 Billion 0.201x -15.30%
2012-12-31 $10.41 Billion $2.47 Billion 0.237x +95.95%
2011-12-31 $10.49 Billion $1.27 Billion 0.121x -29.51%
2010-12-31 $10.37 Billion $1.78 Billion 0.172x +19.24%
2009-12-31 $9.51 Billion $1.37 Billion 0.144x +35.42%
2008-12-31 $9.62 Billion $1.02 Billion 0.106x -24.10%
2007-12-31 $8.69 Billion $1.22 Billion 0.140x -34.22%
2006-12-31 $3.81 Billion $811.70 Million 0.213x -3.11%
2005-12-31 $3.33 Billion $732.50 Million 0.220x +11.57%
2004-12-31 $2.89 Billion $570.90 Million 0.197x -38.07%
2003-12-31 $2.36 Billion $752.40 Million 0.318x +55.07%
2002-12-31 $2.05 Billion $421.70 Million 0.205x --